Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Cancer Vaccines01:30

Cancer Vaccines

616
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
616
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

634
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
634
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

249
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
249
Vaccinations01:51

Vaccinations

49.1K
Overview
49.1K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.4K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Cell-Mediated Immunity of mRNA-1283 Vaccine Encoding SARS-CoV-2 Spike Receptor-Binding and N-Terminal Domains in Preclinical and Clinical Studies.

The Journal of infectious diseases·2026
Same author

Monovalent and multivalent OspA mRNA-LNP vaccines elicit functional antibodies and protect against Borrelia burgdorferi in mice.

NPJ vaccines·2026
Same author

Predictive modeling of immune escape and antigenic grouping of SARS-CoV-2 variants.

Journal of virology·2026
Same author

Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaques.

Immunity·2026
Same author

Maternal expression and breast milk transfer of an mRNA- encoded monoclonal antibody in a murine model of cholera.

PLoS neglected tropical diseases·2026
Same author

Harnessing mRNA for the expression of monoclonal IgG and IgA in non-human primates.

Frontiers in immunology·2026

関連する実験動画

Updated: Nov 12, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.6K

ワクチン開発の新たなアプローチ

Makda S Gebre1, Luis A Brito2, Lisa H Tostanoski3

  • 1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Cell
|March 19, 2021
PubMed
まとめ

RNAやウイルスベクトルプラットフォームのような新種のワクチンは,病原体に挑戦する従来のワクチンの限界に対応しています. バイオマテリアルとエンジニアリングの進歩は ワクチンの開発をさらに強化し 世界的な健康安全保障をもたらします

さらに関連する動画

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.8K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.4K

関連する実験動画

Last Updated: Nov 12, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.6K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.8K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.4K

科学分野:

  • ワクチン学
  • バイオテクノロジー
  • 感染症 研究

背景:

  • 伝統的なワクチンは不可欠ですが,持続性,急速な進化,または新規の病原体との課題に直面しています.
  • 既存のワクチン技術は 複雑な抗原と新たな感染症の脅威と 闘っています

研究 の 目的:

  • 新しいワクチン技術の現状を見直す
  • RNA,ウイルスベクター,バイオマテリアル,ワクチン開発の工学における進歩を強調する.

主な方法:

  • 核酸ワクチン (RNA) に関する現在の文献のレビュー
  • ウイルスベクターワクチン (アデノウイルス) に関する現在の文献のレビュー.
  • ワクチンの開発に関連する生物材料と工学の進歩について議論する.

主要な成果:

  • 新しいワクチンプラットフォームは 伝統的なアプローチの限界を 克服する見込みを示しています
  • RNAとウイルスベクトルワクチンは病原体に好適です.
  • バイオマテリアルとエンジニアリングは ワクチンの有効性や投与を改善するための新しい戦略を提供します

結論:

  • 新種のワクチン技術は,満たされていない公衆衛生のニーズに対処する上で重要な進歩を意味します.
  • RNA,ウイルスベクター,バイオマテリアル,エンジニアリングの継続的な研究は,将来のワクチンのイノベーションにとって極めて重要です.
  • これらの技術は ワクチンの開発に革命を起こし 世界的な健康状態を改善する可能性を秘めています